Sphingolipids in Alzheimer's disease, how can we target them?

Simone M. Crivelli; Caterina Giovagnoni; Lars Visseren; Anna-Lena Scheithauer; Nienke de Wit; Sandra den Hoedt; Mario Losen; Monique T. Mulder; Jochen Walter; Helga E. de Vries; Erhard Bieberich; Pilar Martinez-Martinez

doi:10.1016/j.addr.2019.12.003

Sphingolipids in Alzheimer's disease, how can we target them?

Simone M. Crivelli, Caterina Giovagnoni, Lars Visseren, Anna-Lena Scheithauer, Nienke de Wit, Sandra den Hoedt, Mario Losen, Monique T. Mulder, Jochen Walter, Helga E. de Vries, Erhard Bieberich, Pilar Martinez-Martinez^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	214-231
Number of pages	18
Journal	Advanced Drug Delivery Reviews
Volume	159
DOIs	https://doi.org/10.1016/j.addr.2019.12.003
Publication status	Published - 2020

Keywords

Ceramide
Sphingosine-1-phosphate (S1P)
Sphingomyelin (SM)
Alzheimer's disease
Blood brain barrier (BBB)
GW4869
Tricyclic dibenzoazepines (TCA)
Fingolimod (FTY720)
AMYLOID PRECURSOR PROTEIN
NERVE GROWTH-FACTOR
KINASE-C-ZETA
BLOOD-BRAIN-BARRIER
CERAMIDE SYNTHASE 2
SERINE PALMITOYLTRANSFERASE INHIBITOR
MITOCHONDRIAL OUTER-MEMBRANE
CULTURED HIPPOCAMPAL-NEURONS
P75 NEUROTROPHIN RECEPTOR
ANTIGEN-BINDING PROTEIN

Access to Document

10.1016/j.addr.2019.12.003

Cite this

Crivelli, Simone M. ; Giovagnoni, Caterina ; Visseren, Lars ; Scheithauer, Anna-Lena ; de Wit, Nienke ; den Hoedt, Sandra ; Losen, Mario ; Mulder, Monique T. ; Walter, Jochen ; de Vries, Helga E. ; Bieberich, Erhard ; Martinez-Martinez, Pilar. / Sphingolipids in Alzheimer's disease, how can we target them?. In: Advanced Drug Delivery Reviews. 2020 ; Vol. 159. pp. 214-231.

@article{7edd7faca09c4f84acec9c3d0aec8352,

title = "Sphingolipids in Alzheimer's disease, how can we target them?",

keywords = "Ceramide, Sphingosine-1-phosphate (S1P), Sphingomyelin (SM), Alzheimer's disease, Blood brain barrier (BBB), GW4869, Tricyclic dibenzoazepines (TCA), Fingolimod (FTY720), AMYLOID PRECURSOR PROTEIN, NERVE GROWTH-FACTOR, KINASE-C-ZETA, BLOOD-BRAIN-BARRIER, CERAMIDE SYNTHASE 2, SERINE PALMITOYLTRANSFERASE INHIBITOR, MITOCHONDRIAL OUTER-MEMBRANE, CULTURED HIPPOCAMPAL-NEURONS, P75 NEUROTROPHIN RECEPTOR, ANTIGEN-BINDING PROTEIN",

author = "Crivelli, {Simone M.} and Caterina Giovagnoni and Lars Visseren and Anna-Lena Scheithauer and {de Wit}, Nienke and {den Hoedt}, Sandra and Mario Losen and Mulder, {Monique T.} and Jochen Walter and {de Vries}, {Helga E.} and Erhard Bieberich and Pilar Martinez-Martinez",

year = "2020",

doi = "10.1016/j.addr.2019.12.003",

language = "English",

volume = "159",

pages = "214--231",

journal = "Advanced Drug Delivery Reviews",

issn = "0169-409X",

publisher = "Elsevier Science",

}